NCT03055923View on ClinicalTrials.gov

EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

April 10, 2018

Study Completion Date

April 10, 2018

Conditions
AsthmaChronic Obstructive Pulmonary Disease
Interventions
DEVICE

The Inflammacheck Device

A new hand-held, Non-invasive breathing test, that only requires tidal breathing.

Trial Locations (1)

PO6 3LY

Portsmouth Hospitals NHS Trust, Portsmouth

Sponsors

Collaborators (1)

Asthma UK
All Listed Sponsors
collaborator

Asthma UK

OTHER

lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT03055923 - EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study. | Biotech Hunter | Biotech Hunter